• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GABA(B) 受体的正变构调节剂 rac-BHFF 可抑制酒精的自我给药。

The positive allosteric modulator of the GABA(B) receptor, rac-BHFF, suppresses alcohol self-administration.

机构信息

CNR Neuroscience Institute, Viale Diaz 182, I-09126 Cagliari, Italy.

出版信息

Drug Alcohol Depend. 2010 Jun 1;109(1-3):96-103. doi: 10.1016/j.drugalcdep.2009.12.019. Epub 2010 Jan 20.

DOI:10.1016/j.drugalcdep.2009.12.019
PMID:20089372
Abstract

The present study was designed to extend to the newly synthesized rac-BHFF [(R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one] the investigation on the capacity of positive allosteric modulators of the GABA(B) receptor to reduce alcohol self-administration in rats. To this end, selectively bred Sardinian alcohol-preferring (sP) rats were initially trained to respond on a lever [on a fixed ratio 4 (FR4) schedule of reinforcement] to orally self-administer alcohol (15%, v/v) or sucrose (0.7%, w/v) in daily 30-min sessions. Once responding reached stable levels, the effect of rac-BHFF (0, 50, 100, and 200mg/kg; i.g.) on responding for alcohol and sucrose was determined. Pretreatment with rac-BHFF produced a dose-dependent suppression in responding for alcohol; reduction in the total number of responses for alcohol, in comparison to vehicle-treated rats, averaged approximately 30%, 65%, and 90% in 50, 100, and 200mg/kg rac-BHFF-treated rats, respectively. Pretreatment with 200mg/kg rac-BHFF markedly increased the latency to the first response on the alcohol lever. The effect of pretreatment with rac-BHFF on alcohol self-administration was highly specific, since (a) responding for sucrose was reduced (to approximately 50%, in comparison to vehicle-treated rats) only by pretreatment with 200mg/kg rac-BHFF, and (b) latency to the first response on the sucrose lever was completely unaltered by any rac-BHFF dose. Treatment with rac-BHFF did not alter spontaneous locomotor activity in an independent group of sP rats. The present data constitute a further piece of evidence on the capacity of positive allosteric modulators of the GABA(B) receptor to reduce alcohol's reinforcing properties in rats.

摘要

本研究旨在将新合成的 rac-BHFF[(R,S)-5,7-二叔丁基-3-羟基-3-三氟甲基-3H-苯并呋喃-2-酮]的研究扩展到 GABA(B)受体的正变构调节剂降低大鼠酒精自我给药的能力。为此,最初对选择性繁殖的撒丁岛酒精偏好(sP)大鼠进行训练,使其通过操纵杆对酒精(15%,v/v)或蔗糖(0.7%,w/v)进行口服自我给药,每日 30 分钟。一旦反应达到稳定水平,就确定 rac-BHFF(0、50、100 和 200mg/kg;ig)对酒精和蔗糖的反应的影响。rac-BHFF 预处理产生了剂量依赖性的酒精反应抑制;与 vehicle 处理的大鼠相比,50、100 和 200mg/kg rac-BHFF 处理的大鼠中,酒精总反应数减少了约 30%、65%和 90%。200mg/kg rac-BHFF 预处理显著增加了对酒精操纵杆的第一次反应的潜伏期。rac-BHFF 预处理对酒精自我给药的影响具有高度特异性,因为 (a) 只有在 200mg/kg rac-BHFF 预处理时,蔗糖的反应才会减少(与 vehicle 处理的大鼠相比,减少约 50%),而 (b) 任何 rac-BHFF 剂量都不会改变对蔗糖操纵杆的第一次反应的潜伏期。rac-BHFF 治疗并未改变 sP 大鼠独立组的自发运动活动。目前的数据构成了 GABA(B)受体的正变构调节剂降低大鼠酒精强化特性的能力的进一步证据。

相似文献

1
The positive allosteric modulator of the GABA(B) receptor, rac-BHFF, suppresses alcohol self-administration.GABA(B) 受体的正变构调节剂 rac-BHFF 可抑制酒精的自我给药。
Drug Alcohol Depend. 2010 Jun 1;109(1-3):96-103. doi: 10.1016/j.drugalcdep.2009.12.019. Epub 2010 Jan 20.
2
Reduction of alcohol's reinforcing and motivational properties by the positive allosteric modulator of the GABA(B) receptor, BHF177, in alcohol-preferring rats.正变构调节剂 BHF177 降低酒精偏爱大鼠中 GABA(B)受体的强化和激励特性。
Alcohol Clin Exp Res. 2009 Oct;33(10):1749-56. doi: 10.1111/j.1530-0277.2009.01012.x. Epub 2009 Jul 1.
3
Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen.GABAB受体正向变构调节剂GS39783对酒精动机特性的特异性降低——与GABAB受体直接激动剂巴氯芬的作用比较
Alcohol Clin Exp Res. 2008 Sep;32(9):1558-64. doi: 10.1111/j.1530-0277.2008.00725.x. Epub 2008 Jul 9.
4
Reduction of alcohol intake by the positive allosteric modulator of the GABA(B) receptor, rac-BHFF, in alcohol-preferring rats.GABA(B) 受体正变构调节剂 rac-BHFF 减少酒精偏好大鼠的酒精摄入量。
Alcohol. 2013 Feb;47(1):69-73. doi: 10.1016/j.alcohol.2012.11.002. Epub 2012 Dec 6.
5
gamma-Hydroxybutyric acid (GHB) suppresses alcohol's motivational properties in alcohol-preferring rats.γ-羟基丁酸(GHB)可抑制嗜酒大鼠对酒精的动机性反应。
Alcohol. 2008 Mar;42(2):107-13. doi: 10.1016/j.alcohol.2008.01.001.
6
Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen.GABAB受体正性变构调节剂对大鼠酒精自我给药的抑制作用:缺乏耐受性及巴氯芬的增效作用
Psychopharmacology (Berl). 2015 May;232(10):1831-41. doi: 10.1007/s00213-014-3815-8. Epub 2014 Nov 26.
7
Operant self-administration of ethanol in Sardinian alcohol-preferring rats.撒丁岛酒精偏好大鼠对乙醇的操作性自我给药行为。
Alcohol Clin Exp Res. 2002 Nov;26(11):1678-85. doi: 10.1097/01.ALC.0000036285.62071.DA.
8
Reducing effect of the positive allosteric modulator of the GABA(B) receptor, GS39,783, on alcohol self-administration in alcohol-preferring rats.GABA(B)受体正向变构调节剂GS39,783对嗜酒大鼠酒精自我给药的降低作用。
Psychopharmacology (Berl). 2007 Aug;193(2):171-8. doi: 10.1007/s00213-007-0776-1. Epub 2007 Mar 29.
9
Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats.巴氯芬对嗜酒大鼠酒精强化作用的抑制
Alcohol. 2005 Jul;36(3):161-8. doi: 10.1016/j.alcohol.2005.08.003.
10
The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats.GABA(B)受体变构调节剂CGP7930与巴氯芬一样,可减少嗜酒大鼠对乙醇的操作性自我给药。
Neuropharmacology. 2006 Apr;50(5):632-9. doi: 10.1016/j.neuropharm.2005.11.011. Epub 2006 Jan 9.

引用本文的文献

1
Trait sensitivity to positive feedback is a predisposing factor for several aspects of compulsive alcohol drinking in male rats: behavioural, physiological, and molecular correlates.特质对正反馈的敏感性是雄性大鼠强迫性饮酒的几个方面的易感因素:行为、生理和分子相关性。
Psychopharmacology (Berl). 2024 Jan;241(1):33-47. doi: 10.1007/s00213-023-06460-1. Epub 2023 Sep 8.
2
Delving into the reducing effects of the GABA positive allosteric modulator, KK-92A, on alcohol-related behaviors in rats.深入研究GABA正变构调节剂KK-92A对大鼠酒精相关行为的减轻作用。
Alcohol. 2023 Nov;112:61-70. doi: 10.1016/j.alcohol.2023.07.004. Epub 2023 Jul 24.
3
Neurobiological Bases of Alcohol Consumption After Social Stress.
社交应激后饮酒的神经生物学基础。
Curr Top Behav Neurosci. 2022;54:245-281. doi: 10.1007/7854_2021_273.
4
Reducing effect of the novel positive allosteric modulator of the GABA receptor, COR659, on binge-like alcohol drinking in male mice and rats.新型 GABA 受体正变构调节剂 COR659 对雄性小鼠和大鼠 binge-like 饮酒行为的抑制作用。
Psychopharmacology (Berl). 2022 Jan;239(1):201-213. doi: 10.1007/s00213-021-06022-3. Epub 2021 Nov 23.
5
The Novel Positive Allosteric Modulator of the GABA Receptor, KK-92A, Suppresses Alcohol Self-Administration and Cue-Induced Reinstatement of Alcohol Seeking in Rats.新型γ-氨基丁酸(GABA)受体正变构调节剂KK-92A可抑制大鼠的酒精自我给药及线索诱导的酒精觅求复燃。
Front Cell Dev Biol. 2021 Oct 28;9:727576. doi: 10.3389/fcell.2021.727576. eCollection 2021.
6
GABA Receptors and Alcohol Use Disorders: Preclinical Studies.GABA 受体与酒精使用障碍:临床前研究。
Curr Top Behav Neurosci. 2022;52:157-194. doi: 10.1007/7854_2020_178.
7
Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.制定更好的策略开发治疗酒精使用障碍的新药:从过去的成功和失败中吸取教训,塑造更美好的未来。
Neurosci Biobehav Rev. 2019 Aug;103:384-398. doi: 10.1016/j.neubiorev.2019.05.014. Epub 2019 May 18.
8
Potential of GABA Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder.GABA 受体正变构调节剂在治疗酒精使用障碍中的潜力。
CNS Drugs. 2019 Feb;33(2):107-123. doi: 10.1007/s40263-018-0596-3.
9
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABA and cannabinoid CB receptors.COR659 对大鼠酒精、蔗糖和巧克力自主摄取的抑制作用:涉及 GABA 和大麻素 CB 受体。
Psychopharmacology (Berl). 2017 Sep;234(17):2525-2543. doi: 10.1007/s00213-017-4644-3. Epub 2017 May 24.
10
Rat animal models for screening medications to treat alcohol use disorders.用于筛选治疗酒精使用障碍药物的大鼠动物模型。
Neuropharmacology. 2017 Aug 1;122:201-243. doi: 10.1016/j.neuropharm.2017.02.004. Epub 2017 Feb 16.